Literature DB >> 10333239

Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor.

P P Jagodzinski1, A Wierzbicki, J Wustner, Y Kaneko, D Kozbor.   

Abstract

High-molecular-weight dextran sulfate (HMDS) inhibits infection of CD4+ lymphocytes by T-cell (T)-tropic human immunodeficiency virus (HIV) isolates, but augments replication of macrophage (M)-tropic isolates in primary human macrophages and phorbol myristate acetate (PMA)-differentiated THP-1 monocytic cells. To address the mechanism responsible for HMDS-mediated increases in HIV replication in macrophages, we analyzed the interaction between HMDS and functional domains of gp120 on the surface of PMA-differentiated THP-1 cells infected with M-tropic HIV isolates. Immunofluorescence staining of the infected cells revealed that HMDS inhibited the binding of monoclonal antibodies (mAbs) directed to the V3 and C4 domains of gp120, but augmented the binding of three neutralizing antibodies directed to the V2 region of gp120. The extent of HMDS-mediated changes within the V2 loop of gp120 was associated with increased virus binding and replication in PMA-differentiated THP-1 cells and primary macrophages. The effect was dependent on expression of the CCR5 receptor and was inhibited by the beta-chemokine RANTES. Results of this study suggest that HMDS-mediated increases in HIV infection in macrophages are associated with conformational changes within the V2 region of gp120 and enhanced interaction between gp120 and the CCR5 coreceptor on the target cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333239     DOI: 10.1089/vim.1999.12.23

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  6 in total

1.  Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.

Authors:  Erica B Schleifman; Ranjit Bindra; Jean Leif; Jacob del Campo; Faye A Rogers; Pradeep Uchil; Olaf Kutsch; Leonard D Shultz; Priti Kumar; Dale L Greiner; Peter M Glazer
Journal:  Chem Biol       Date:  2011-09-23

2.  Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.

Authors:  Dong-Seong Lee; Kyeong-Eun Jung; Cheol-Hee Yoon; Hong Lim; Yong-Soo Bae
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Authors:  Raman Bahal; Nicole Ali McNeer; Danith H Ly; W Mark Saltzman; Peter M Glazer
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

4.  Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.

Authors:  Secondo Sonza; Adam Johnson; David Tyssen; Tim Spelman; Gareth R Lewis; Jeremy R A Paull; Gilda Tachedjian
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

5.  Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Fred C Krebs
Journal:  Virol J       Date:  2012-01-26       Impact factor: 4.099

6.  Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity.

Authors:  Stuart G Turville; Meropi Aravantinou; Todd Miller; Jessica Kenney; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Tom M Zydowsky; Michael Piatak; Julian W Bess; Jeffrey D Lifson; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.